Literature DB >> 3931732

Oxidative transformations of arachidonic acid in human dispersed lung cells: disparity between the utilization of endogenous and exogenous substrate.

J Harvey, S T Holgate, B J Peters, C Robinson, J R Walker.   

Abstract

Eicosanoid release from human dispersed lung cells (HDLC) containing ca 5% mast cells was studied before and after cell activation with ionophore A23187 or anti-IgE. Basal release of eicosanoids synthesized from endogenous arachidonate was measured by radioimmunoassay. In descending order of abundance the products were: 5-hydroxyeicosatetraenoic acid (5-HETE) greater than thromboxane B2 (TXB2) greater than prostaglandin F2 alpha (PGF2 alpha) approximately immunoreactive (i)-PGE2 greater than PGD2 greater than 6-keto-PGF1 alpha approximately i-LTC4. Stimulation of HDLC with ionophore A23187 or, after passive sensitization, with anti-IgE resulted in 2-10 fold increases in the generation of individual eicosanoids. In terms of net generation the most abundant products were PGD2 and TXB2 with either stimulus. Activation with A23187 caused net release of i-LTC4 and 5-HETE, but these products were not measured after immunological activation. A more complete profile of lipoxygenase products released from HDLC dispersed from one lung was obtained after separation by high performance liquid chromatography combined with ultra violet spectroscopy and bioassay. The major products released from the cells from this lung with ionophore stimulation were 13-hydroxylinoleic acid greater than LTB4 greater than 5-HETE greater than 12-HETE greater than LTC4 greater than 15-HETE greater than 11-HETE approximately 9-HETE. When the utilization of exogenous [14C]-arachidonic acid for prostanoid biosynthesis was compared to that of endogenous unlabelled arachidonate the formation of TXB2 was consistently underestimated. These results imply compartmentalization of arachidonic acid utilization in Ca2+-activated HDLC. In unstimulated cells the proportional formation of PGD2 was overestimated when exogenous arachidonic acid was substrate. After activation with A23187 the proportions of PGD2 were similar with both substrate sources. The large proportions of PGD2 and TXB2 generated by HDLC further supports the view that these eicosanoids may be important inflammatory mediators in lung tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931732      PMCID: PMC1916706          DOI: 10.1111/j.1476-5381.1985.tb08911.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Thromboxane A2 biosynthesis in human lung fibroblasts WI-38.

Authors:  N K Hopkins; F F Sun; R R Gorman
Journal:  Biochem Biophys Res Commun       Date:  1978-11-29       Impact factor: 3.575

Review 2.  Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma.

Authors:  C Robinson; S T Holgate
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

3.  Metabolism of prostaglandin endoperoxide in animal tissues.

Authors:  F F Sun; J P Chapman; J C McGuire
Journal:  Prostaglandins       Date:  1977

4.  Evidence for functionally distinct pools of phospholipase responsible for prostaglandin release from the perfused guinea-pig lung.

Authors:  C Robinson; J R Hoult
Journal:  Eur J Pharmacol       Date:  1980-06-27       Impact factor: 4.432

5.  The release of spasmogenic substances from human chopped lung tissue and its inhibition.

Authors:  P J Piper; J L Walker
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

6.  Differences in biological activation of arachidonic acid in perfused lungs from guinea pig, rat and man.

Authors:  F Al-Ubaidi; Y S Bakhle
Journal:  Eur J Pharmacol       Date:  1980-03-07       Impact factor: 4.432

7.  Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium.

Authors:  S Moncada; A G Herman; E A Higgs; J R Vane
Journal:  Thromb Res       Date:  1977-09       Impact factor: 3.944

8.  Comparative studies on immunologically and non-immunologically produced slow-reacting substances from man, guinea-pig and rat.

Authors:  H R Morris; P J Piper; G W Taylor; J R Tippins
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

9.  Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.

Authors:  R A Lewis; K F Austen; J M Drazen; D A Clark; A Marfat; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Incorporation and metabolism of [14C]-arachidonic acid in guinea-pig lungs.

Authors:  P J Jose; J P Seale
Journal:  Br J Pharmacol       Date:  1979-12       Impact factor: 8.739

View more
  2 in total

1.  Effect of inhaled piriprost (U-60, 257) a novel leukotriene inhibitor, on allergen and exercise induced bronchoconstriction in asthma.

Authors:  J S Mann; C Robinson; A Q Sheridan; P Clement; M K Bach; S T Holgate
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

2.  Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man.

Authors:  N Curzen; P Rafferty; S T Holgate
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.